Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06780709 · ClinicalTrials.gov registry record · NA
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
A NA study of Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06780709 is a NA study of Neuromyelitis Optica Spectrum Disorder (NMOSD) that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06780709, a NA study of Neuromyelitis Optica Spectrum Disorder (NMOSD), is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be designed as a randomized controlled trial, randomizing patients to immediately starting the program as well as a 6 month delayed start. The intervention would leverage an existing clinical comprehensive MS wellness program at the Corinne Dickinson for Multiple Sclerosis (MS) at Mount Sinai Medical Center. The primary endpoint of this study would be evaluating quality of life, as assessed by MS-Quality of Life -54.
Conditions Studied
Interventions
- BEHAVIORAL Wellness Program and Behavioral Counseling
Study Locations (1)
New York
- Corinne Goldsmith Dickinson Center for MS at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06780709
The ClinicalTrials.gov registry entry for NCT06780709 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuromyelitis Optica Spectrum Disorder (NMOSD) appearing as the primary indexed condition, and to 1 intervention - of which Wellness Program and Behavioral Counseling is the first listed.
NCT06780709 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06780709 about?
NCT06780709 is a clinical study titled "Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD". This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical thera...
What is the current status of trial NCT06780709?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-01-21. Estimated completion is 2028-01.
What conditions does trial NCT06780709 study?
This clinical trial studies the following conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD).
What interventions are being tested in trial NCT06780709?
The interventions under investigation include: Wellness Program and Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06780709?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06780709 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.